Does Metformin Increase Paraoxonase Activity in Patients with the Metabolic Syndrome? Additional Data from the MEFISTO Study
In a subanalysis on the metformin, arterial function, intima‐media thickness, and nitroxidation in the metabolic syndrome (MEFISTO)(8) (an open‐label fashion, with 1 year of 850 mg daily of metformin) subjects’ samples, we measured the paraoxonase 1 (PON1) activity in 39 patients that finished the s...
Na minha lista:
Publicado no: | Clin Transl Sci |
---|---|
Main Authors: | , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Blackwell Publishing Inc
2012
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5439879/ https://ncbi.nlm.nih.gov/pubmed/22686204 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1752-8062.2012.00391.x |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|